Header Logo

Connection

Ira Targoff to Dermatomyositis

Back to Details
This is a "connection" page, showing publications Ira Targoff has written about Dermatomyositis.
Ira Targoff
Connection Strength
5.116
Dermatomyositis
  1. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum. 2007 Apr; 56(4):1295-303.
    View in: PubMed
    Score: 0.278
  2. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006 Nov; 54(11):3682-9.
    View in: PubMed
    Score: 0.270
  3. Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features. Rheumatology (Oxford). 2023 02 23; 62(SI2):SI226-SI234.
    View in: PubMed
    Score: 0.209
  4. Idiopathic inflammatory myopathy: autoantibody update. Curr Rheumatol Rep. 2002 Oct; 4(5):434-41.
    View in: PubMed
    Score: 0.204
  5. Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies. Ann Rheum Dis. 2023 Feb; 82(2):235-245.
    View in: PubMed
    Score: 0.203
  6. Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis. Rheumatology (Oxford). 2022 07 06; 61(7):2969-2977.
    View in: PubMed
    Score: 0.200
  7. Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes. Pediatr Rheumatol Online J. 2022 Apr 12; 20(1):28.
    View in: PubMed
    Score: 0.197
  8. Corticosteroid discontinuation, complete clinical response and remission in juvenile dermatomyositis. Rheumatology (Oxford). 2021 05 14; 60(5):2134-2145.
    View in: PubMed
    Score: 0.185
  9. Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America. Rheumatology (Oxford). 2021 04 06; 60(4):1839-1849.
    View in: PubMed
    Score: 0.184
  10. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies. Arthritis Res Ther. 2020 04 06; 22(1):69.
    View in: PubMed
    Score: 0.171
  11. Long-term outcomes in Juvenile Myositis patients. Semin Arthritis Rheum. 2020 02; 50(1):149-155.
    View in: PubMed
    Score: 0.162
  12. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2019 07; 78(7):988-995.
    View in: PubMed
    Score: 0.160
  13. Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis. Rheumatology (Oxford). 2018 11 01; 57(11):1956-1963.
    View in: PubMed
    Score: 0.155
  14. Medications received by patients with juvenile dermatomyositis. Semin Arthritis Rheum. 2018 12; 48(3):513-522.
    View in: PubMed
    Score: 0.149
  15. The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis. Semin Arthritis Rheum. 2018 12; 48(3):504-512.
    View in: PubMed
    Score: 0.148
  16. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2018 05; 77(5):714-719.
    View in: PubMed
    Score: 0.147
  17. Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. J Clin Invest. 1995 Oct; 96(4):1730-7.
    View in: PubMed
    Score: 0.125
  18. Analysis of the Mi-2 autoantigen of dermatomyositis. Arthritis Rheum. 1995 Jan; 38(1):123-8.
    View in: PubMed
    Score: 0.119
  19. Primary structure and functional expression of human Glycyl-tRNA synthetase, an autoantigen in myositis. J Biol Chem. 1994 Nov 18; 269(46):28790-7.
    View in: PubMed
    Score: 0.118
  20. Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am. 1994 Nov; 20(4):857-80.
    View in: PubMed
    Score: 0.118
  21. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Medicine (Baltimore). 2014 Nov; 93(24):318-332.
    View in: PubMed
    Score: 0.118
  22. Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis. Arthritis Rheum. 2013 Jul; 65(7):1934-41.
    View in: PubMed
    Score: 0.107
  23. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol. 1993 Jan; 100(1):116S-123S.
    View in: PubMed
    Score: 0.104
  24. Antinuclear antibodies: clinical correlations and biologic significance. Adv Dermatol. 1992; 7:3-52; discussion 53.
    View in: PubMed
    Score: 0.097
  25. Diagnosis and treatment of polymyositis and dermatomyositis. Compr Ther. 1990 Apr; 16(4):16-24.
    View in: PubMed
    Score: 0.086
  26. Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheum. 2009 Aug; 60(8):2499-504.
    View in: PubMed
    Score: 0.082
  27. Humoral immunity in polymyositis and dermatomyositis. Mt Sinai J Med. 1988 Nov; 55(6):487-93.
    View in: PubMed
    Score: 0.078
  28. Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies. Arthritis Rheum. 2008 Oct; 58(10):3239-46.
    View in: PubMed
    Score: 0.077
  29. Laboratory manifestations of polymyositis/dermatomyositis. Clin Dermatol. 1988 Apr-Jun; 6(2):76-92.
    View in: PubMed
    Score: 0.074
  30. Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine (Baltimore). 2008 Mar; 87(2):70-86.
    View in: PubMed
    Score: 0.074
  31. Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups. Arthritis Rheum. 2005 Aug; 52(8):2433-8.
    View in: PubMed
    Score: 0.062
  32. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum. 1985 Jul; 28(7):796-803.
    View in: PubMed
    Score: 0.062
  33. Nucleolar localization of the PM-Scl antigen. Arthritis Rheum. 1985 Feb; 28(2):226-30.
    View in: PubMed
    Score: 0.060
  34. Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum. 2003 Aug; 48(8):2285-93.
    View in: PubMed
    Score: 0.054
  35. Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol. 2000 Nov; 12(6):475-81.
    View in: PubMed
    Score: 0.045
  36. Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci. Arthritis Rheum. 1999 Jun; 42(6):1285-90.
    View in: PubMed
    Score: 0.040
  37. Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol. 1997 Nov; 9(6):527-35.
    View in: PubMed
    Score: 0.036
  38. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum. 1997 Jul; 40(7):1257-66.
    View in: PubMed
    Score: 0.035
  39. Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. Arthritis Rheum. 1996 Oct; 39(10):1769-71.
    View in: PubMed
    Score: 0.034
  40. Clinical significance of specific autoantibodies in juvenile dermatomyositis. J Rheumatol. 1996 Oct; 23(10):1794-7.
    View in: PubMed
    Score: 0.034
  41. Autoantibodies to glycyl-transfer RNA synthetase in myositis. Association with dermatomyositis and immunologic heterogeneity. Arthritis Rheum. 1996 Jan; 39(1):146-51.
    View in: PubMed
    Score: 0.032
  42. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J Clin Invest. 1993 Jun; 91(6):2556-64.
    View in: PubMed
    Score: 0.027
  43. Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum. 1992 Jul; 35(7):821-30.
    View in: PubMed
    Score: 0.025
  44. Clinical, serologic, and immunogenetic studies in patients with dermatomyositis. Acta Derm Venereol. 1991; 71(4):312-6.
    View in: PubMed
    Score: 0.023
  45. Polymyositis. Immunol Ser. 1991; 54:201-46.
    View in: PubMed
    Score: 0.023
  46. Antibody to signal recognition particle in polymyositis. Arthritis Rheum. 1990 Sep; 33(9):1361-70.
    View in: PubMed
    Score: 0.022
  47. Immunologic aspects of myositis. Curr Opin Rheumatol. 1989 Dec; 1(4):432-42.
    View in: PubMed
    Score: 0.021
  48. Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum. 1988 Apr; 31(4):515-24.
    View in: PubMed
    Score: 0.019
  49. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore). 2005 Jul; 84(4):231-249.
    View in: PubMed
    Score: 0.015
  50. Antibodies to Mi-1 in SLE: relationship to other precipitins and reaction with bovine immunoglobulin. Clin Exp Immunol. 1983 Jul; 53(1):76-82.
    View in: PubMed
    Score: 0.013
  51. Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis. Arthritis Rheum. 2002 Jul; 46(7):1885-93.
    View in: PubMed
    Score: 0.012
  52. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy. Arthritis Rheum. 1998 Apr; 41(4):710-9.
    View in: PubMed
    Score: 0.009
  53. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore). 1991 Nov; 70(6):360-74.
    View in: PubMed
    Score: 0.006
  54. Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum. 1991 Nov; 34(11):1391-6.
    View in: PubMed
    Score: 0.006
  55. C4 null genes in American whites and blacks with myositis. J Rheumatol. 1990 Mar; 17(3):331-4.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.